The Technical Analyst
Science 37 Holdings, Inc. [SNCE]
Exchange: NASDAQ Global Market Sector: Healthcare Industry: Health Information Services
Science 37 Holdings, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
6.73% $0.300
America/New_York / 27 mar 2023 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 35.01 mill |
| EPS: | 0 |
| P/E: | 0 |
| Earnings Date: | May 08, 2023 |
| SharesOutstanding: | 116.73 mill |
| Avg Daily Volume: | 0.931 mill |
| RATING 2023-03-27 |
|---|
| B- |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Neutral | |
| P/E: | Neutral | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | |||||
|---|---|---|---|---|---|
| 3/20 | 3/21 | 4/21 | 1/22 | 2/22 | |
| Revenue | n/a | n/a | n/a | n/a | |
| Gr.Profit | n/a | n/a | n/a | ||
| Ebit | n/a | n/a | |||
| Asset | n/a | n/a | |||
| Debt | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE 0 | industry: PE 0 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.250 - 0.350 ( +/- 16.67%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-03-10 | Shipton Michael | Buy | 522 793 | Restricted Stock Units |
| 2022-11-17 | Pellizzari Christine A | Buy | 5 000 | Common Stock |
| 2022-10-07 | Von Autenried Paul | Buy | 46 040 | Restricted Stock Units |
| 2022-10-07 | Shipton Michael | Buy | 300 000 | Restricted Stock Units |
| 2022-08-12 | Geffon Steven | Buy | 563 414 | Restricted Stock Units |
| INSIDER POWER |
|---|
| 83.52 |
| Last 84 transactions |
| Buy: 69 284 191 | Sell: 3 549 942 |
Forecast:
16:00 - $0.300
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $0.300
Forecast 2: 16:00 - $0.300
Forecast 3: 16:00 - $0.300
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.300 (6.73% ) |
| Volume | 0.144 mill |
| Avg. Vol. | 0.931 mill |
| % of Avg. Vol | 15.50 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For SNCE
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
SNCE
Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data. Its platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating agile clinical trials; and extensive configuration to support virtually any phase of clinical study and any indication. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.
Latest Press Releases
2023-03-10 17:25:00 - Press Release
Science 37 Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Research triangle park, n.c., march 10, 2023 (globe newswire) -- science 37 holdings, inc. (nasdaq: snce), the industry-leading metasite™, today announced the granting of inducement equity awards under the science 37 holdings, inc. 2022 employment inducement incentive award plan (the “plan”). the plan was approved by science 37's board of directors in november 2022. in accordance with nasdaq listing rule 5635(c)(4), the awards were approved by science 37's compensation committee and made as a material inducement to the non-executive employees' entry into employment with the company.
2023-03-06 06:00:00 - Press Release
Science 37 Reports Fourth Quarter And Full Year 2022 Financial Results
Research triangle park, n.c., march 06, 2023 (globe newswire) -- science 37 holdings, inc. (nasdaq: snce), (“science 37”), the industry-leading metasite™, today reported its financial results for the quarter and full year ended december 31, 2022.
2023-02-10 17:18:00 - Press Release
Science 37 Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Research triangle park, n.c., feb. 10, 2023 (globe newswire) -- science 37 holdings, inc. (nasdaq: snce), the industry-leading metasite™, today announced the granting of inducement equity awards under the science 37 holdings, inc. 2022 employment inducement incentive award plan (the “plan”). the plan was approved by science 37's board of directors in november 2022. in accordance with nasdaq listing rule 5635(c)(4), the awards were approved by science 37's compensation committee and made as a material inducement to the non-executive employees' entry into employment with the company.
2023-01-06 17:29:00 - Press Release
Science 37 Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Research triangle park, n.c., jan. 06, 2023 (globe newswire) -- science 37 holdings, inc. (nasdaq: snce), the industry-leading metasite™, today announced the granting of an inducement equity award under the science 37 holdings, inc. 2022 employment inducement incentive award plan (the “plan”). the plan was approved by science 37's board of directors in november 2022. in accordance with nasdaq listing rule 5635(c)(4), the award was approved by science 37's compensation committee and made as a material inducement to the non-executive employee's entry into employment with the company.
2022-12-09 17:36:00 - Press Release
Science 37 Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Research triangle park, n.c., dec. 09, 2022 (globe newswire) -- science 37 holdings, inc. (nasdaq: snce), the industry-leading metasite™, today announced the granting of an inducement equity award under the science 37 holdings, inc. 2022 employment inducement incentive award plan (the “plan”). the plan was approved by science 37's board of directors in november 2022. in accordance with nasdaq listing rule 5635(c)(4), the award was approved by science 37's compensation committee and made as a material inducement to the non-executive employee's entry into employment with the company.
Latest News
2023-03-13 08:41:32 - InvestorPlace
Why Is Science 37 (SNCE) Stock Up 9% Today?
Science 37 (NASDAQ: SNCE ) stock is rising higher on Monday following news of inducement equity awards for its Metasite employees. According to a press release from Science 37, the awards were approved by its Board of Directors in November 2022.
2023-02-23 08:30:00 - GlobeNewsWire
Science 37 to Present at the Cowen 43rd Annual Health Care Conference
RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the company will be participating in the upcoming Cowen 43rd Annual Health Care Conference in Boston.
2023-02-21 08:30:00 - GlobeNewsWire
Science 37 to Report Fourth Quarter 2022 Financial Results on March 6, 2023
RESEARCH TRIANGLE PARK, N.C., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report fourth quarter 2022 financial results prior to the market open on Monday, March 6, 2023.
2022-11-30 16:05:00 - GlobeNewsWire
Science 37 to Present at the 5ᵗʰ Annual Evercore ISI HealthCONx Conference
RESEARCH TRIANGLE PARK, N.C., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Science 37® Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the company will be participating in the upcoming 5th Annual Evercore ISI HealthCONx Conference.
2022-11-11 13:14:04 - Seeking Alpha
Science 37 Holdings, Inc. (SNCE) Q3 2022 Earnings Call Transcript
Start Time: 08:30 January 1, 0000 9:07 AM ET Science 37 Holdings, Inc. (NASDAQ:SNCE ) Q3 2022 Earnings Conference Call November 11, 2022, 08:30 AM ET Company Participants David Coman - CEO Mike Zaranek - CFO Steve Halper - Managing Director, LifeSci Advisors Conference Call Participants Steven Braun - Cowen Max Smock - William Blair Matthew Hewitt - Craig-Hallum Frank Takkinen - Lake Street Eric Coldwell - Baird David Windley - Jefferies Operator Good day and thank you for standing by. Welcome to the Science 37 Third Quarter 2022 Earnings Conference Call.
2022-11-10 18:48:26 - Zacks Investment Research
Science 37 Holdings, Inc. (SNCE) Reports Q3 Loss, Misses Revenue Estimates
Science 37 Holdings, Inc. (SNCE) delivered earnings and revenue surprises of 5.88% and 21.12%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
2022-11-01 07:55:00 - GlobeNewsWire
Science 37 to Report Third Quarter 2022 Financial Results on November 10, 2022
RESEARCH TRIANGLE PARK, N.C., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report third quarter 2022 financial results after the market closes on Thursday, November 10, 2022. Company management will host a corresponding conference call on Friday, November 11, 2022, at 8:30 a.m. Eastern Time.
2022-09-08 16:01:00 - GlobeNewsWire
Science 37 to Present at the Baird 2022 Global Healthcare Conference
RESEARCH TRIANGLE PARK, N.C., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Science 37® Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be participating in the upcoming Baird Global Healthcare Conference in New York.
2022-08-14 23:34:06 - Seeking Alpha
Science 37 Holdings, Inc. (SNCE) CEO David Coman on Q2 2022 Results - Earnings Call Transcript
Science 37 Holdings, Inc. (NASDAQ:SNCE ) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Caroline Paul - Investor Relations David Coman - Chief Executive Officer Mike Zaranek - Chief Financial Officer Conference Call Participants Charles Rhyee - Cowen Justin Lin - William Blair Matt Hewitt - Craig-Hallum Frank Takkinen - Lake Street Operator Hello, thank you for standing by and welcome to the Science 37 Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
2022-07-28 07:55:00 - GlobeNewsWire
Science 37 to Report Second Quarter 2022 Financial Results on August 11, 2022
RESEARCH TRIANGLE PARK, N.C., July 28, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report second quarter 2022 financial results before the market opens on Thursday, August 11, 2022. Company management will host a corresponding conference call at 8:30 a.m. Eastern Time.